Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Group Regulatory News (COST)

Share Price Information for Costain Group (COST)

Share Price is delayed by 15 minutes
Get Live Data
207.00    -3.50 (-1.66%)
Bid:
205.50
Ask:
206.00
Spread: 0.50 (0.243%)
Market Cap: £551.69m
COST Live PriceLast checked at - London Stock Exchange

Intraday Costain Group Share Chart

Scrip Dividend Reference Price

28 Apr 2025 12:32

RNS Number : 4662G
Costain Group PLC
28 April 2025
 

 

 

Costain Group PLC (the 'Company')

28 April 2025

 

Scrip Dividend Reference Price

 

The Company announces that the Scrip Dividend Reference Price for the fully paid shares in the Company to be issued to shareholders who elect to receive the scrip dividend alternative for the final dividend for the year ending 31 December 2024 is 104.88 pence per ordinary share.

The Scrip Dividend Reference Price has been calculated as the average value of the middle market quotations for the Company's ordinary shares as derived from the Daily Official List of the London Stock Exchange for the five consecutive dealing days commencing on the ex-dividend date. The Company's ordinary shares were marked ex-dividend on 17 April 2025.

Further Information:

Shareholders wishing to receive the scrip dividend in respect of the final dividend for the year ending 31 December 2024 and who have not already submitted a mandate form should return a mandate form to the Registrar, Equiniti, Share Dividend Team, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA by 7 May 2025.

For more information regarding the scrip dividend including the terms, and to download the mandate form, see Costain scrip

If you have already completed a valid scrip dividend mandate form, it will remain valid until you cancel your election and you need not return any further documentation to receive this scrip dividend.

The final dividend for the year ending 31 December 2024, including the scrip dividend, will be paid on 29 May 2025 (the dividend payment date), subject to approval at the 2025 Annual General Meeting on 15 May 2025, to the ordinary shareholders of the Company on the register at close of business on 22 April 2025 (the record date).

For further information, please contact Equiniti on +44 (0)371 384 2268*.

 

Enquiries

 

Investors and analysts

Matt Jones, Costain

matt.jones@costain.com

+44 (0)7860 922341

 

Financial media - Headland

costain@headlandconsultancy.com

Andy Rivett-Carnac

+44 (0) 7968 997365

Charlie Twigg

+44 (0) 7946 494568

 

 

* Please use the country code when calling from outside the UK. Lines are open from 08:30 to 17:30 (UK time), Monday to Friday (excluding public holidays in England and Wales).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVPPUBPCUPAGGR
Date   Source Headline
3rd Jan 20178:00 amRNSBlock listing Interim Review
16th Dec 20167:00 amRNSContract
14th Dec 201610:00 amRNSTransfer of Shares
1st Dec 20169:53 amRNSHolding(s) in Company
30th Nov 201610:11 amRNSHolding(s) in Company
30th Nov 20168:00 amRNSTotal Voting Rights
29th Nov 20163:36 pmRNSResult of Placing
29th Nov 20162:42 pmRNSProposed Placing
21st Nov 20167:00 amRNSContract
15th Nov 20167:00 amRNSContract
4th Nov 20161:48 pmRNSDirector/PDMR Shareholding
1st Nov 20169:37 amRNSTotal Voting Rights
31st Oct 20167:00 amRNSTotal Voting Rights
27th Oct 20167:00 amRNSBlock Listing Application
19th Oct 20164:36 pmRNSDividend Declaration - Amendment
18th Oct 20168:00 amRNSDividend - Scrip Alternative
27th Sep 201612:38 pmRNSDirector/PDMR Shareholding
23rd Sep 201611:06 amRNSHolding(s) in Company
22nd Sep 201611:43 amRNSScrip Dividend Reference Price
20th Sep 201612:57 pmRNSHolding(s) in Company
6th Sep 201612:11 pmRNSDirector/PDMR Shareholding
1st Sep 201612:13 pmRNSHolding(s) in Company
30th Aug 20164:28 pmRNSHolding(s) in Company
30th Aug 20164:08 pmRNSHolding(s) in Company
24th Aug 20167:00 amRNSHalf-year Report
11th Jul 201610:16 amRNSDirector Declaration
6th Jul 20167:00 amRNSAcquisition
30th Jun 201612:53 pmRNSDirector/PDMR Shareholding
30th Jun 20168:57 amRNSBlock listing Interim Review
30th Jun 20167:00 amRNSTrading Update
17th Jun 20167:00 amRNSBusiness Briefing
31st May 20169:00 amRNSTotal Voting Rights
17th May 20167:00 amRNSDividend - Scrip Alternative
16th May 20163:03 pmRNSDirector/PDMR Shareholding
5th May 20164:51 pmRNSResult of AGM
5th May 20167:01 amRNSLTIP Listing Application
5th May 20167:00 amRNSAGM Statement
25th Apr 20167:00 amRNSHolding(s) in Company
21st Apr 20162:05 pmRNSScrip Dividend Reference Price
18th Apr 201610:22 amRNSHolding(s) in Company
7th Apr 20167:00 amRNSDirector/PDMR Shareholding
6th Apr 20167:00 amRNSAppointment of Chairman Designate
4th Apr 201610:38 amRNSDirector/PDMR Shareholding
31st Mar 201610:32 amRNSNotice of AGM
2nd Mar 20167:00 amRNSFinal Results
1st Feb 20167:00 amRNSRe Contract
21st Jan 20169:07 amRNSHolding(s) in Company
11th Jan 20167:00 amRNSConfirmation of Contract Award
7th Jan 201612:17 pmRNSHolding(s) in Company
6th Jan 20167:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.